Concepedia

Author

Monique Steijaert

Erasmus University Rotterdam

Also Known As

M M Steijaert, M Steijaert, M. Steijaert, M.M.C. Steijaert, Monique M. C. Steijaert, Monique M. Steijaert, Monique M.C Steijaert, Monique M.C. Steijaert, Monique Steijaert, Steijaert, M

20

Publications

815

Citations

13

H-Index

23

Concepts

All Affiliations

Erasmus University RotterdamErasmus MCHovonAntwerp University HospitalIsala
MS

About

Monique Steijaert is an author at Erasmus University Rotterdam specializing in medicine, health sciences, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

132

2

Health Sciences

2

2

94

3

Applied Physiology

1

1

39

4

Blood Transplantation

1

1

55

5

Cellular Therapies

1

1

55

Monique Steijaert

×

13

Publications

812

Citations

13

H-Index

YearCitations

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff,

Journal of Clinical Oncology

2003

168

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt,

Blood

2003

163

Partially T-Cell–Depleted Allogeneic Stem-Cell Transplantation for First-Line Treatment of Multiple Myeloma: A Prospective Evaluation of Patients Treated in the Phase III Study HOVON 24 MM

Henk M. Lokhorst, Christine M. Segeren, Leo F. Verdonck,

Journal of Clinical Oncology

2003

79

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high‐dose chemotherapy in patients with multiple myeloma

Ka Lung Wu, Berna Beverloo, Henk M. Lokhorst,

British Journal of Haematology

2007

73

Self‐reported quality of life in elderly patients with aggressive non‐Hodgkin's lymphoma treated with CHOP chemotherapy

Jeanette K. Doorduijn, Ivonne Buijt, Bronno van der Holt,

European Journal Of Haematology

2005

67

A randomized multicenter comparison of CD34+-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

Jan J. Cornelissen, Bronno van der Holt, Eefke Petersen,

Experimental Hematology

2003

55

Human obesity: from lipid abnormalities to lipid oxidation.

Luc F. Van Gaal, Angi Zhang, Monique Steijaert,

PubMed

1995

49

The use of multi-frequency impedance to determine total body water and extracellular water in obese and lean female individuals

Monique Steijaert, Paul Deurenberg, L. Van Gaal,

International Journal of Obesity

1997

39

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:

Simon Daenen, Bronno van der Holt, Gregor Verhoef,

Leukemia Research

2004

38

Impact of Three Courses of Intensified CHOP Prior to High-Dose Sequential Therapy Followed by Autologous Stem-Cell Transplantation As First-Line Treatment in Poor-Risk, Aggressive Non-Hodgkin's Lymphoma: Comparative Analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40

Gustaaf W. van Imhoff, Bronno van der Holt, Marius MacKenzie,

Journal of Clinical Oncology

2005

24

Page 1